Cargando…

Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring

BACKGROUND: The implication of IL-6 in the pathogenesis of epithelial ovarian cancer (EOC) is well documented. Accordingly, the clinicopathological significance of this cytokine in patients’ ascites fluid or serum has largely been investigated. Since the main source of IL-6 secreted into the biologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masoumi-Moghaddam, Samar, Amini, Afshin, Wei, Ai-Qun, Robertson, Gregory, Morris, David L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539669/ https://www.ncbi.nlm.nih.gov/pubmed/26282935 http://dx.doi.org/10.1186/s13048-015-0183-x

Ejemplares similares

Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2015)

Initial Report on Differential Expression of Sprouty Proteins 1 and 2 in Human Epithelial Ovarian Cancer Cell Lines
por: Moghaddam, Samar Masoumi, et al.
Publicado: (2012)

The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2014)

Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
por: Masoumi Moghaddam, Samar, et al.
Publicado: (2011)

Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application
por: Amini, Afshin, et al.
Publicado: (2012)

The developing story of Sprouty and cancer
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2014)

Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects
por: Amini, Afshin, et al.
Publicado: (2014)

Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy
por: Amini, Afshin, et al.
Publicado: (2014)

Depletion of mucin in mucin-producing human gastrointestinal carcinoma: Results from in vitro and in vivo studies with bromelain and N-acetylcysteine
por: Amini, Afshin, et al.
Publicado: (2015)

Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21)
por: Amini, Afshin, et al.
Publicado: (2013)

The growth of Ehrlich's ascites carcinoma in C3H mice and in mice of an unrelated closed colony. Variation in tumour growth, cytology and ascites formation.
por: Hartveit, F.
Publicado: (1966)

Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma
por: Ho, Chih-Ming, et al.
Publicado: (2012)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
por: Choi, Jung-A, et al.
Publicado: (2023)

Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2017)

Ascitic complement system in ovarian cancer
por: Bjørge, L, et al.
Publicado: (2005)

The bright side of ascites in ovarian cancer
por: Cohen, Marie, et al.
Publicado: (2014)

Ascites Volumes and the Ovarian Cancer Microenvironment
por: Penet, Marie-France, et al.
Publicado: (2018)

The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells
por: Pakuła, Martyna, et al.
Publicado: (2019)

Etiology of Ascites and Pleural Effusion Associated with Ovarian Tumors: Literature Review and Case Reports of Three Ovarian Tumors Presenting with Massive Ascites, but without Peritoneal Dissemination
por: Miyoshi, Ai, et al.
Publicado: (2015)

Effect of ovarian cancer ascites on SKOV-3 cells proteome: new proteins associated with aggressive phenotype in epithelial ovarian cancer
por: Toledo-Leyva, Alfredo, et al.
Publicado: (2018)

Mediation Analysis Reveals Potential Biological Mechanism of Ascites Influencing Recurrence in Patients with Epithelial Ovarian Cancer
por: Yang, Chunyan, et al.
Publicado: (2020)

Disaggregation and invasion of ovarian carcinoma ascites spheroids
por: Burleson, Kathryn M, et al.
Publicado: (2006)

Deciphering the ovarian cancer ascites fluid peptidome
por: Bery, Anand, et al.
Publicado: (2014)

Chlamydia Peritonitis and Ascites Mimicking Ovarian Cancer
por: Gojayev, Anar, et al.
Publicado: (2016)

Immune Tumor Microenvironment in Ovarian Cancer Ascites
por: Almeida-Nunes, Diana Luísa, et al.
Publicado: (2022)

Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma
por: Sedlar, Ales, et al.
Publicado: (2013)

Ovarian Epithelial-Stromal Interactions: Role of Interleukins 1 and 6
por: Woolery, Kamisha T., et al.
Publicado: (2011)

Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
por: Shi, Gang, et al.
Publicado: (2021)

Humanized Mouse Model of Ovarian Cancer Recapitulates Patient Solid Tumor Progression, Ascites Formation, and Metastasis
por: Bankert, Richard B., et al.
Publicado: (2011)

Urinary Ascites: An Imitator of Portal Hypertension-Related Ascites
por: Zhuang, Tony Z, et al.
Publicado: (2022)

Sheet Formation by Cells of an Ascites Tumour in vitro
por: Trevan, D. J., et al.
Publicado: (1960)

Exosomes in ovarian cancer ascites promote epithelial–mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p
por: Cai, Jing, et al.
Publicado: (2021)

Mirk kinase inhibition targets ovarian cancer ascites
por: Deng, Xiaobing, et al.
Publicado: (2014)

The untapped potential of ascites in ovarian cancer research and treatment
por: Ford, Caroline Elizabeth, et al.
Publicado: (2020)

Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors
por: Bonde, Anne-Katrine, et al.
Publicado: (2012)

Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
por: Lane, Denis, et al.
Publicado: (2015)

Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery(∗): A Prospective Substudy of a Randomized Controlled Trial
por: Hunsicker, Oliver, et al.
Publicado: (2015)

Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer
por: Li, Yiqun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mroialeme7vp3hmmhtudfdnvlh